Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.13
-0.2357-0.38%
Post-market: 61.130.00000.00%16:10 EDT
Volume:18.04K
Turnover:1.10M
Market Cap:270.19M
PE:20.00
High:61.34
Open:61.15
Low:60.74
Close:61.36
52wk High:64.10
52wk Low:39.36
Shares:4.42M
Float Shares:4.42M
Volume Ratio:0.28
T/O Rate:0.41%
Dividend:1.53
Dividend Rate:2.50%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Guardant Health Shares Climb Following Outlook Raise

Dow Jones
·
Jul 31

FDA Priority Review For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD)

Simply Wall St.
·
Jul 31

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Roivant Sciences price target raised to $35 from $31.50 at BofA

TIPRANKS
·
Jul 31

Guardant Health is Maintained at Buy by BTIG

Dow Jones
·
Jul 31

BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate

Benzinga Earnings
·
Jul 31

Brightspring Health Services Q2 Net Income USD 87 Million

THOMSON REUTERS
·
Jul 31

Brightspring Health Services - Sees Fy2026 Revenue $15.10 Bln-$15.43 Bln, up 17%-19.5%

THOMSON REUTERS
·
Jul 31

Brightspring Health Services Inc Fy2026 REV View $15.06 Bln

THOMSON REUTERS
·
Jul 31

Brightspring Health Services - Sees Fy2026 Adj Ebitda $820 Mln-$845 Mln, up 32.8%-36.8%

THOMSON REUTERS
·
Jul 31

Brightspring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

THOMSON REUTERS
·
Jul 31

BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

GlobeNewswire
·
Jul 31

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS
·
Jul 31

Guardant Health files automatic mixed securities shelf

TIPRANKS
·
Jul 31

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS
·
Jul 31

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31